Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
CC transcript

HOSPIRA INC (HSP) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/03/2015 8-K Quarterly results
08/27/2015 8-K Other Events
07/29/2015 10-Q Quarterly Report for the period ended June 30, 2015
07/29/2015 8-K Quarterly results
Docs: "Hospira, Inc. Condensed Consolidated Statements of Income Three Months Ended June 30, % Change 2015 2014 Net sales $ 1,183.6 $ 1,135.8"
06/24/2015 8-K Other Events
05/13/2015 8-K Submission of Matters to a Vote of Security Holders
05/12/2015 8-K Submission of Matters to a Vote of Security Holders
05/11/2015 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 6.9% stake in HOSPIRA INC
04/28/2015 10-Q Quarterly Report for the period ended March 31, 2015
04/28/2015 8-K Quarterly results
Docs: "Hospira, Inc. Condensed Consolidated Statements of Income Three Months Ended March 31, % Change 2015 2014 Net sales $ 1,174.9 $ 1,050.8"
04/10/2015 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
04/07/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "FDA Warning Letter"
03/31/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
03/20/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
03/20/2015 DEF 14A Form DEF 14A - Other definitive proxy statements
03/19/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
03/11/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
02/27/2015 8-K Other Events
02/26/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
02/12/2015 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 12.6% stake in HOSPIRA INC
02/12/2015 SC 13G WELLINGTON MANAGEMENT GROUP LLP reports a 6.6% stake in Hospira, Inc.
02/12/2015 10-K Annual Report for the period ended December 31, 2014
02/12/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
02/12/2015 8-K Quarterly results
Docs: "Hospira, Inc. Condensed Consolidated Statements of Income Three Months Ended December 31, % Change 2014 2013 Net sales $ 1,126.5 $ 1,084.4"
02/10/2015 SC 13G/A VANGUARD GROUP INC reports a 7.7% stake in Hospira Inc
02/09/2015 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Agreement and Plan of Merger, among Pfizer Inc., Perkins Holding Company and Hospira, Inc",
"Amended and Restated Bylaws of Hospira, Inc., as amended as of February 4, 2015",
"Form of Amendment to Agreement Regarding Change in Control"
02/09/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
02/05/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
02/05/2015 8-K Other Events, Financial Statements and Exhibits
Docs: "Pfizer To Acquire Hospira"
02/05/2015 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
02/03/2015 SC 13G FRANKLIN MUTUAL ADVISERS LLC reports a 5.9% stake in HOSPIRA, INC.
01/22/2015 SC 13G/A BlackRock Inc. reports a 8.6% stake in HOSPIRA INC
01/13/2015 8-K Cost Associated with Exit or Disposal Activities, Material Impairments
01/12/2015 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Private Securities Litigation Reform Act of 1995 — A Caution Concerning Forward-Looking Statements"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy